Supply first-class Ibrutinib 936563-96-1 with favorable price
Quick Detail:
| CAS No.: |
936563-96-1 |
Other Names: |
Ibrutinib |
MF: |
Ibrutinib |
|
EINECS No.: |
936563-96-1 |
Place of Origin: |
shanxi , China (Mainland) |
Type: |
Antineoplastic Agents |
|
Grade Standard: |
Medicine Grade |
Brand Name: |
wango |
Model Number: |
Ibrutinib 936563-96-1 |
|
Purity: |
98% Ibrutinib |
Chemical Name: |
Ibrutinib |
Appearance: |
White Solid |
|
Identification: |
should conform |
Composition Test: |
should conform |
PH: |
6.5~7.5 |
|
Loss on Drying: |
NMT5.0% |
Usage: |
antineoplastics |
Specification:
|
Test |
Specification |
Result |
|
Appearance |
White to Off-white solid |
Off-white solid |
|
Identification by NMR |
To match with the reference standard |
Conforms |
|
Purity |
≥99.0% |
99.5% |
|
Total impurities |
≤1.0% |
0.5% |
|
Single impurity |
≤0.2% |
0.2% |
|
Chiral purity |
≥99.0% |
99.5% |
|
KF |
≤1.0% |
0.5% |
|
Solvent |
MTBE≤3000ppm THF≤72PPm methyl alcohol≤3000ppm EA:≤5000ppm 2-Me-THf≤720ppm methylbenzene≤400ppm |
Conforms |
|
Conclusion |
Complies with in-house standard. |
|
Function :
Ibrutinib is a cancer drug that targets B-cell malignancies such as certain leukemias and lymphomas.
 |